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Abstract 
A straightforward synthesis of the Met antagonist JLK1360 involving an alkylation-
cyclocondensation process using aminothiazole 1 and nitrophenacyl bromide 2, reduction of the 
nitro group, and coupling of the resulting tetracyclic aniline 5 with an appropriate N-acyl alanine 
derivative, is reported. 
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Introduction  
 
The hepatocyte growth factor receptor, also known as the mesenchymal–epithelial transition 
factor (c-Met), is a tyrosine kinase receptor present in both normal and malignant cells. Its 
activation promotes a variety of effects, such as cell proliferation or angiogenesis, leading to 
invasiveness and metastasis. Moreover, it is well recognized that this receptor type is over-
expressed and mutated in a variety of human cancer types and constitutes a therapeutic target for 
the development of selective new anti-cancer drugs. The main pharmacological interest is to find 
drugs capable of preventing receptor autophosphorylation.  
In this context, compound JLK1360, in a concentration range between 100 to 250 nM, 
inhibited cell scattering and branching morphogenesis.1 These effects are due to its capacity to 
impair receptor signalling and restoration after degradation. From computational studies 
(docking and molecular dynamics) it is well assumed that this compound interacts with this 
receptor at the ATP-binding pocket. The high degree of selectivity of JLK1360 was assessed by 
computational and also biochemical studies. 
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Results and Discussion 
 
We report herein the details of the synthesis of JLK1360. The commercially available 2-amino-
5-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 12 was chosen as the starting material of the 
synthesis. We planned to take advantage of the 2-aminothiazole moiety of 1 to assemble the 
tricyclic tetrahydroimidazo[2’,1’:2,3]-thiazolo[5,4-c]pyridine skeleton by an alkylation-
cyclocondensation process with an appropriate phenacyl bromide.3 A final acylation of the C-2 
p-aminophenyl substituent using an activated N-(phenylacetyl)alanine would complete the 
synthesis. 
The key aniline tricyclic intermediate 5 was prepared in 40% overall yield in a 
straightforward manner by reaction of thiazolopyridine 1 with p-nitrophenacyl bromide 2 in 
refluxing i-PrOH, followed by reduction of the nitro moiety of the resulting 2-aryl substituted 
imidazothiazolopyridine 4 using SnCl2 in concentrated hydrochloric acid and methanol at reflux. 
Minor amounts of the chlorinated derivative 6 were also formed (Scheme 1). When the initial 
step was performed in refluxing toluene, alkylation at the ring nitrogen occurred to give the 
imino derivative 3,4 which was subsequently cyclized to 4, although in low overall yield (~10%), 
by heating in a methanol solution. 
Significant 1H NMR signals of compound 4 are two doublets due to the aromatic protons of 
the p-nitrophenyl substituent, a singlet for the proton of the imidazole moiety, two signals 
attributable to the N-benzyl and N-allyl methylene protons, and two triplets due to the CH2-CH2 
fragment of the tetrahydropyridine ring. 
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Scheme 1. Synthesis of the 2-aryltetrahydro[2’,1’:2,3]thiazolo[5,4-c]pyridine fragment. 
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On the other hand, the required amido acid 8 was prepared by coupling of (S)-alanine methyl 
ester with 3,5-difluorophenylacetic acid using DCC as the condensing agent, followed by 
alkaline hydrolysis of the resulting amido ester 7, as outlined in Scheme 2.5 
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Scheme 2. Synthesis of amido acid 8. 
 
The final step of the synthesis was the condensation reaction between the tricyclic aniline 
derivative 5 and N-acylalanine 8. We initially used BOP6 as the coupling reagent7 in the presence 
of HOBt and DIPEA (Scheme 3). Although the desired target JLK1360 was obtained in 
acceptable yield (50%), its complete purification by column chromatography proved to be 
difficult due to the presence of a minor impurity. The use of BOPCl8 as the coupling reagent in 
the presence of HOBt and DIPEA gave more satisfactory results in terms of chromatographic 
purification, leading to pure JLK1360 in 47% yield. 
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Scheme 3. Condensation reaction. 
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Both the 1H and 13C NMR data were in complete agreement with the structure of JLK1360. 
Seven groups of signals are present in the aliphatic region of the 1H NMR spectrum, attributable 
to the five methylene groups and the methine and methyl protons of the alanine moiety. The 
assignments (see Experimental Part) were confirmed by bidimentional COSY and HSQC 
experiments. 
The use of aniline 5 as a platform for the synthesis of JLK1360 analogues following a 
similar synthetic sequence is in progress.  
 
 
Experimental Section 
 
General Procedures. Reagents and chemicals were purchased from commercial sources 
[Sigma-Aldrich S.A., Riedel-de Haën (SnCl2), and Fluorochem (3,5-difluorophenylacetic acid)] 
and used as received. 2-Amino-5-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 1 was 
purchased from UKR Org. Synthesis Ltd. All non-aqueous reactions were performed under an 
argon or nitrogen atmosphere with dry, freshly distilled solvents using standard procedures. 
Drying of organic extracts during the work-up of reactions was performed over anhydrous 
Na2SO4 or MgSO4. Evaporation of solvents was accomplished with a rotatory evaporator. Thin-
layer chromatography was done on SiO2 (silica gel 60 F254), and the spots were located by UV 
and either a 1% KMnO4 solution or iodine. Chromatography refers to flash column 
chromatography and was carried out on SiO2 (silica gel 60, 230-400 mesh). NMR spectra were 
recorded at 300 or 400 MHz (1H) and 75.4 or 100.6 MHz (13C), and chemical shifts are reported 
in δ values downfield from TMS or relative to residual chloroform (7.26 ppm, 77.0 ppm) as an 
internal standard. Melting points were determined in a capillary tube and are uncorrected. 
Optical rotation was recorded on a Perkin Elmer Model 241 Polarimeter. 
 
7-Benzyl-2-(p-nitrophenyl)-5,6,7,8-tetrahydroimidazo[2’,1’:2,3]thiazolo[5,4-c]pyridine (4). 
2-Amino-5-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine (1; 1.0 g, 4.08 mmol) and 2-bromo-
p-nitroacetophenone (2; 1.09 g, 4.48 mmol) were dissolved in anhydrous i-PrOH (6 mL), and the 
mixture was heated at reflux for 50 minutes. The reaction was controlled by TLC analysis (1:1 
EtOAc-hexane). When the reaction was complete, the resulting mixture was cooled to rt and 
concentrated under vacuum to afford crude compound 4 (Rf = 0.21 in 1:1 EtOAc-hexane), which 
was used in the next step without further purification. Column chromatography (1:1 EtOAc-
hexane containing a few drops of NEt3) afforded pure 4 as an orange solid: mp 68-69 ºC; 1H 
NMR (400 MHz, CDCl3) δ 2.81 (t, J = 6.0 Hz, 2H), 3.01 (t, J = 6.0 Hz, 2H), 3.61 (s, 2H), 3.78 
(s, 2H), 7.27-7.37 (m, 5H, HAr), 7.70 (s, 1H), 7.94 (dm, J = 8.8 Hz, 2H, HAr), 8.22 (dm, J = 8.8 
Hz, 2H, HAr); 13C NMR (100.6 MHz, CDCl3) δ 23.0 (CH2), 48.7 (CH2), 50.5 (CH2), 61.4 (CH2), 
107.8 (CH), 120.6 (CAr), 124.2 (2CHAr), 124.5 (CAr), 125.2 (2CHAr), 127.6 (CHAr), 128.5 
(2CHAr), 129.0 (2CHAr), 137.5, 140.7, 144.4, 146.5 (CAr). MS (EI) m/z (rel intensity) 391 (M+, 
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20), 384 (24), 369 (36), 368 (46), 367 (49), 366 (39), 351 (31), 350 (25), 337 (15), 277 (24), 276 
(17), 261 (20), 261 (100), 260 (49), 259 (43), 258 (23), 257 (20) 122 (28), 106 (26). 
2-(p-Aminophenyl)-7-benzyl-5,6,7,8-tetrahydroimidazo[2’,1’:2,3]thiazolo[5,4-c]pyridine (5). 
SnCl2 (2.53 g, 13.3 mmol) was added to a stirred suspension of the above crude 4 in MeOH 
(90 mL). Then, 37% aqueous HCl (90 mL) was slowly added, and the resulting mixture was 
heated at reflux for 30 minutes. The reaction was controlled by TLC analysis (2:1 EtOAc-
hexane). When the reaction was complete, 2M aqueous K2CO3 was added to the mixture until 
pH~9. The resulting precipitate was filtered and chromatographed (EtOAc containing a few 
drops of NEt3) to give compound 5 (588 mg, 40% overall yield from 1; Rf = 0.14 in 2:1 EtOAc-
hexane) as a brown solid. Minor amounts of the chlorinated derivative 6 (16 mg) were also 
isolated. 5: mp 135-137 ºC; 1H NMR (400 MHz, CDCl3) δ 2.71 (t, J = 6.0 Hz, 2H), 2.95 (t, J = 
6.0 Hz, 2H), 3.56 (s, 2H), 3.73 (s, 2H), 6.69 (dm, J = 8.4 Hz, 2H, CHAr), 7.25-7.36 (m, 5H, 
CHAr), 7.39 (s, 1H), 7.60 (dm, J = 8.4 Hz, 2H, CHAr); 13C NMR (100.6 MHz, CDCl3) δ 22.9 
(CH2), 48.7 (CH2); 50.8 (CH2), 61.2 (CH2), 104.1 (CH), 115.2 (2CHAr), 118.4, 124.5, 125.0 
(CAr), 126.1 (2CHAr), 127.4 (CHAr), 128.4 (2CHAr), 129.0 (2CHAr), 137.6, 145.6, 147.0, 148.0 
(CAr). HMRS calcd for [C21H20N4S + H]: 361.1481, found: 361.1479. 6: mp 148-150 ºC; 1H 
NMR (400 MHz, CDCl3) δ 2.94 (t, J = 6.0 Hz, 2H), 3.13 (m, 2H), 3.56 (t, J = 2.0 Hz, 2H), 3.74 
(s, 2H), 6.72 (dm, J = 9.2 Hz, 2H, CHAr), 7.28-7.36 (m, 5H, CHAr), 7.75 (dm, J = 9.2 Hz, 2H, 
CHAr); 13C NMR (100.6 MHz, CDCl3) δ 23.7 (CH2), 48.9 (CH2), 50.6 (CH2), 61.3 (CH2), 105.1 
(CAr), 114.9 (2CHAr), 119.3, 123.4, 125.4 (CAr), 127.5 (CHAr), 127.8 (2CHAr), 128.5 (2CHAr), 
129.0 (2CHAr), 137.5, 140.7, 145.9, 146.4 (CAr). HMRS calcd for [C21H19ClN4S + H]: 395.1092, 
found: 395.1086. 
(S)-Methyl 2-[(3,5-difluorophenyl)acetamido]propanoate (7). DCC (8.66 g, 42.0 mmol) was 
added to a solution of L-alanine methyl ester hydrochloride (4.0 g, 28.0 mmol) and 3,5-
difluorophenylacetic acid (4.8 g, 28.0 mmol) in CH2Cl2 (320 mL). After stirring at rt for 10 
minutes, DMAP (1.71 g, 14.0 mmol) was added in small portions, and the resulting mixture was 
stirred for 48 h and then concentrated under vacuum. Flash chromatography (1:1 EtOAc-hexane) 
afforded compound 7 (5.90 g, 82% yield; Rf  = 0.54 in 1:1 EtOAc-hexane) as a pale yellow solid: 
mp 75-76 ºC; 1H NMR (400 MHz, CDCl3) δ 1.39 (d, J = 7.2 Hz, 3H, CH3), 3.55 (s, 2H), 3.74 (s, 
3H, OCH3), 4.58 (qd, J = 7.2 Hz, 1H), 6.26 (br s., 1H, NH), 6.73 (tt, J = 9.2, 2.4 Hz, 1H, CHAr), 
6.84 (m, 2H, CHAr); 13C NMR (100.6 MHz, CDCl3) δ 18.2 (CH3), 42.8 (CH2), 48.2 (CH), 52.5 
(CH3), 102.8 (t, JC-F = 24.9 Hz, CHAr), 112.2 (dd, JC-F = 18.7, 7.0 Hz, CHAr), 138.2 (t, JC-F = 10.1 
Hz, CAr), 163.0 (dd, JC-F = 248.5, 12.5 Hz, CAr), 169.0, 173.3 (C=O). HMRS calcd for 
[C12H13F2NO3 + H]: 258.0936, found: 258.0936.  
(S)-2-[(3,5-Difluorophenyl)acetamido]propanoic acid (8). 1 M aqueous NaOH (79 mL, 78.8 
mmol) was added to a solution of ester 7 (4.5 g, 17.5 mmol) in MeOH (196 mL), and the mixture 
was stirred at rt for 24 h. Water was added, and the MeOH was eliminated under vacuum. The 
aqueous layer was acidified to pH~3, and the solution was extracted with EtOAc. The combined 
extracts were washed with water and brine, dried, and concentrated. Saturated aqueous NaHCO3 
was added to the resulting solid residue, and the suspension was extracted with CH2Cl2. The 
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aqueous phase was neutralized and extracted with EtOAc. The combined ethyl acetate extracts 
were washed with water and brine, dried, and concentrated under vacuum to afford pure 
compound 8 (2.89 g, 68% yield; Rf = 0.15 in EtOAc containing a few drops of NEt3) as a white 
solid: mp 108-109 ºC; 1H NMR (300 MHz, CD3OD) δ 1.39 (d, J = 7.2 Hz, 3H, CH3), 3.54 (d, J = 
14.8 Hz, 1H, CH2), 3.58 (d, J = 14.8 Hz, 1H, CH2), 4.37 (q, J = 7.2 Hz, 1H, CH), 6.80 (tt, J = 
9.2, 2.4 Hz, 1H, CHAr), 6.92 (m, 2H, CHAr); 13C NMR (100.6 MHz, CD3OD) δ 18.4 (CH3), 43.6 
(CH2), 50.4 (CH), 103.8 (t, JC-F = 25.6 Hz, CHAr), 114.0 (dd, JC-F = 18.7, 7.0 Hz, CHAr), 141.9 (t, 
JC-F = 9.3 Hz, CAr), 165.2 (dd, JC-F = 246.8, 13.3 Hz, CAr), 173.3, 176.8 (C=O). HMRS calcd for 
[C11H11F2NO3 + H]: 244.0780, found: 244.0781.  
(S)-N-[4-(7-Benzyl-5,6,7,8-tetrahydroimidazo[2’,1’:2,3]thiazolo[5,4-c]pyridin-2-yl)phenyl]-
2-[(3,5-difluorophenyl)acetamido]propanamide (JLK1360). Procedure A. To a mixture of 
compound 8 (120 mg, 0.49 mmol) and activated 4 Å MS in CH2Cl2 (8 mL) were added BOP 
(217 mg, 0.49 mmol), HOBt (66 mg, 0.49 mmol), and DIPEA (214 µl, 1.23 mmol). The resulting 
mixture was stirred at rt for 20 minutes, and then a solution of amine 5 (89 mg, 0.25 mmol) in 
CH2Cl2 (3 mL) was added via a cannula. After 24 h of continuous stirring at rt, the reaction was 
quenched with saturated aqueous NaHCO3. The aqueous layer was extracted with EtOAc, and 
the combined organic extracts were washed with water and brine, dried, and concentrated. Flash 
chromatography (6:4 to 7:3 EtOAc-hexane) afforded compound JLK1360 (72 mg, 50% yield; Rf 
= 0.25 in 4:1 EtOAc-hexane) as a yellow solid. Procedure B. To a mixture of compound 8 (74 
mg, 0.31 mmol) and activated 4 Å MS in CH2Cl2 (4 mL) were added BOPCl (105 mg, 0.42 
mmol), HOBt (56 mg, 0.42 mmol), and DIPEA (192 µl, 1.10 mmol). The resulting mixture was 
stirred at rt for 20 minutes, and then a solution of amine 5 (100 mg, 0.28 mmol) in CH2Cl2 (3 
mL) was slowly transferred via a cannula. After 48 h of continuous stirring at rt, the reaction was 
quenched with saturated aqueous NaHCO3 and filtered through Celite®. The aqueous layer was 
extracted with EtOAc and the combined organic extracts were washed with water and brine, 
dried and concentrated. Flash chromatography (CH2Cl2 to 98:2 CH2Cl2-MeOH) afforded 33 mg 
of amine 5 and compound JLK1360 (51 mg, 47% yield based on consumed 5) as a yellow solid: 
mp 205-207 ºC; 1H NMR (400 MHz, CDCl3) δ 1.43 (d, J = 7.2 Hz, 3H, CH3), 2.74 (t, J = 5.6 Hz, 
2H, NCH2CH2), 2.97 (t, J = 5.6 Hz, 2H, NCH2CH2), 3.54 (s, 2H, CH2CO), 3.57 (s, 2H, NCH2), 
3.76 (s, 2H, CH2Ar), 4.71 (qd, J = 7.2 Hz, 1H, CH), 6.69 (t, J = 9.2 Hz, 1H, CHAr), 6.78 (d, J = 
9.2 Hz, 1H, CHAr), 6.79 (d, J = 9.2 Hz, 1H, CHAr), 6.97 (br s, 1H, NH), 7.26-7.36 (m, 5H, CHAr), 
7.45 (dm, J = 7.2 Hz, 2H, CHAr), 7.46 (s, 1H, CHAr), 7.69 (dm, J = 7.2 Hz, 2H, CHAr), 8.80 (br s, 
1H, NH); 13C NMR (100.6 MHz, CDCl3) δ 17.9 (CH3), 22.9 (NCH2CH2), 42.7 (CH2CO), 48.7 
(NCH2CH2), 49.8 (CH), 50.4 (NCH2), 61.3 (CH2Ar), 102.9 (t, JC-F = 24.9 Hz, CHAr), 105.5 (CH), 
112.2 (dd, JC-F = 18.7, 7.0 Hz, CHAr), 119.1 (CAr), 120.2 (CHAr), 124.5 (CAr), 125.6, 127.5, 
128.5, 129.0 (CHAr), 130.6, 136.6, 137.6 (CAr), 138.0 (t, JC-F = 10.1 Hz, CAr), 146.1, 148.4 (CAr), 
163.1 (dd, JC-F = 249.2, 13.3 Hz, CAr), 170.1 (C=O), 170.2 (C=O); [α]22D –7.6 (c 0.11, MeOH). 
HMRS calcd for [C32H29F2N5O2S + H]: 586.2083, found: 586.2071. 
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